COVID-19 Pandemisi Sırasında Obsesif-Kompulsif Bozukluk Belirtilerinin Şiddetindeki Artışa İlişkin Hastaların Algısı

Öz

Amaç: Bu çalışmanın amacı, obsesif kompulsif bozukluğu olan hastaların COVID-19 pandemisi sırasında semptomlarındaki değişiklikleri nasıl algıladıklarını ve bu değişiklikleri hangi faktörlerin etkilediğini incelemektir. Materyal ve Metot: Çalışmanın örneklemini 08.04.2021- 08.10.2021 tarihleri arasında sosyal medya aracılığıyla ulaşılan 262 obsesif-kompulsif tanılı birey oluşturmaktadır. Verilerin toplanmasında tanımlayıcı bilgi formu ve 41 maddelik Padua Envanteri kullanılmıştır. Bulgular: Pandemi süresince hastalık belirtilerinde artış olduğunu bildiren hastaların temizlik ürünlerine ulaşamama ve doktor/terapiste ulaşamama kaygısı yüksekti. Pandemi sırasında, örneklemin %79'u obsesif-kompulsif bozukluk semptomlarında artış olduğunu bildirmiştir. Sonuç: Obsesif-kompulsif bozukluğu olan hastaların rehabilitasyon hizmetleri ekibindeki psikiyatri hemşireleri tarafından düzenli olarak taranması önemlidir. Bu hastalar endişelerini ifade etmeye teşvik edilmeli ve herhangi bir psikolojik stres veya sıkıntı tanımlanmalıdır. Gerektiğinde, hastalar daha fazla yardım için ikinci basamak sağlık hizmetlerine yönlendirilmelidir.

Anahtar Kelimeler

• Anksiyete
• COVID-19
• obsesif-kompulsif bozukluk
• padua envanteri

Patients’ Perceptions of the Increase in Severity of Obsessive-Compulsive Disorder Symptoms during the COVID-19 Pandemic

Abstract

Objective: This study aimed to examine how patients with obsessive-compulsive disorder perceived changes in their symptoms during the COVID-19 pandemic and what factors influenced those changes. Materials and Methods: The sample of the study consists of 262 individuals diagnosed with obsessive-compulsive who were reached through social media between 08.04.2021 and 08.10.2021. A descriptive information form and a 41-item questionnaire based on the Padua Inventory were used to collect the data. Results: During the pandemic, anxiety about not being able to access cleaning products and doctors/therapists was high in the patients who reported a rise in disease symptoms. During the pandemic, 79% of the sample reported an increase in symptoms of obsessive-compulsive disorder. Conclusion: It is essential to conduct regular screenings of patients with obsessive-compulsive disorder by the psychiatric nurses in the rehabilitation services team. These patients should be encouraged to express their concerns, and any psychological stress or distress should be identified. When necessary, patients should be referred to secondary care services for further assistance.

Keywords

• Anxiety
• COVID-19
• obsessive-compulsive disorder
• padua inventory

Kaynakça

1. Banerjee DD. The other side of COVID-19: Impact on obsessive compulsive disorder (OCD) and hoarding. Psychiatry Re. 2020;288:112966. doi:10.1016/j.psychres.2020.112966
2. Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. The New England Journal of Medicine. 2020;383:510-512. doi:10.1056/NEJMp2008017
3. Rodríguez-Rey R, Garrido-Hernansaiz H, Collado S. Psychological impact and associated factors during the initial stage of the Coronavirus (COVID-19) pandemic among the general population in Spain. Front Psychol. 2020;11:1540. doi:10.3389/fpsyg.2020.01540
4. Sønderskov KM, Dinesen PT, Santini ZI, Østergaard SD. The depressive state of Denmark during the COVID-19 pandemic. Acta Neuropsychiatr. 2020;32(4):226–228. doi:10.1017/neu.2020.15
5. Tanir Y, Karayagmurlu A, Kaya İ, et al. Exacerbation of obsessive compulsive disorder symptoms in children and adolescents during COVID-19 pandemic. Psychiatry Res. 2020;293:113363.
6. American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington, VA: American Psychiatric Publishing Incorporated; 2013. doi:10.1176/appi.books.9780890425596
7. Alhusseini NK, Sajid MR, Altayeb A, Alyousof S, Alsheikh HA, Alqahtani A, et al. Depression and obsessive-compulsive disorders amid the COVID-19 pandemic in Saudi Arabia. Cureus. 2021;13(1):e12978. doi:10.7759/cureus.12978
8. Davide P, Andrea P, Martina O, Escelsior A, Davide D, Mario A. The impact of the COVID-19 pandemic on patients with OCD: Effects of contamination symptoms and remission state before the quarantine in a preliminary naturalistic study. Psychiatry Res. 2020;291:113213. doi:10.1016/j.psychres.2020.113213

9. Benatti B, Albert U, Maina G, et al. What happened to patients with obsessive compulsive disorder during the COVID-19 pandemic? A multicentre report from tertiary clinics in Northern Italy. Front Psychiatry. 2020;11:720. doi:10.3389/fpsyt.2020.00720
10. Chakraborty A, Karmakar S. Impact of COVID-19 on obsessive compulsive disorder (OCD). Iran J Psychiatry. 2020;15(3):256–259. doi:10.18502/ijps.v15i3.3820
11. Schwartz-Lifshitz M, Basel D, et al. Obsessive compulsive symptoms severity among children and adolescents during COVID-19 first wave in Israel‏. J Obsessive Compuls Relat Disord. 2021;28:100610. doi:10.1016/j.jocrd.2020.100610
12. Jelinek L, Moritz S, Miegel F, Voderholzer U. Obsessive-compulsive disorder during COVID-19: Turning a problem into an opportunity? J Anxiety Disord. 2021;77:102329.
13. Liao J, Liu L, Fu X, et al. The immediate and long-term impacts of the COVID-19 pandemic on patients with obsessive-compulsive disorder: A one-year follow-up study. Psychiatry Res. 2021;306:114268. doi:10.1016/j.psychres.2021.114268
14. Moreira-de-Oliveira ME, de Menezes GB, Loureiro CP, Laurito LD, Albertella L, Fontenelle LF. The impact of COVID-19 on patients with OCD: A one-year follow-up study. J Psychiatr Res. 2022;147:307–312. doi:10.1016/j.jpsychires.2022.01.065
15. Kalaycıoğlu O, Akhanlı SE. The importance and main principles of power analysis in health research: Application examples on medical case studies Turk J Public Health. 2020;18(1):103-112.
16. Van Oppen P, Hoekstra RJ, Emmelkamp PMG. The structure of obsessive-compulsive symptoms. Behaviour Research and Therapy. 1995;33(1):15–23. doi:10.1016/0005-7967(94)E0010-G
17. Besiroğlu L, Agargun M, Boysan M, Eryonucu B, Guleç M, Selvi Y. The assessment of obsessive-compulsive symptoms: The reliability and validity of the Padua Inventory in a Turkish Population. Turkish Journal of Psychiatry. 2005;16:179–189.
18. Inal C, Gunay S. Probability and mathematical statistics. 2nd ed. Ankara, Türkiye; 2013.
19. Abba-Aji A, Li D, Hrabok M, et al. COVID-19 pandemic and mental health: prevalence and correlates of new-onset obsessive-compulsive symptoms in a Canadian province. Int J Environ Res Public Health. 2020;17(19):6986. doi:10.3390/ijerph17196986
20. Khosravani V, Aardema F, Ardestani SMS, Bastan FS. The impact of the coronavirus pandemic on specific symptom dimensions and severity in OCD: A comparison before and during COVID-19 in the context of stress responses. Journal of Obsessive-Compulsive and Related Disorders. 2021;29:100626.
21. McGuire JF, Piacentini J, Lewin AB, Brennan EA, Murphy TK, Storch EA. A meta-analysis of cognitive behavior therapy and medication for child obsessive-compulsive disorder: moderators of treatment efficacy, response, and remission. Depression and Anxiety. 2015;32(8):580–593. doi:10.1002/da.22389
22. Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries. Research in Social and Administrative Pharmacy. 2021;17(1):2023–2026. doi:10.1016/j.sapharm.2020.04.007
23. Wu T, Jia X, Shi H, et al. Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis. J Affect Disord. 2021;15;281:91–98. doi:10.1016/j.jad.2020.11.117
24. Carmi L, Ben-Arush O, Fostick L, Cohen H, Zohar J. Obsessive compulsive disorder during Coronavirus disease 2019 (COVID-19): 2- and 6-Month follow-ups in a clinical trial. International Journal of Neuropsychopharmacology. 201;24(9):703–709. doi:10.1093/ijnp/pyab024
25. Fontenelle LF, Miguel EC. The impact of COVID‐19 in the diagnosis and treatment of obsessive‐compulsive disorder. Depress Anxiety. 2020; 37:510-511.
26. Sun N, Wei L, Wang H, et al. Qualitative study of the psychological experience of COVID-19 patients during hospitalization. J Affect Disord. 2021;278:15–22. doi:10.1016/j.jad.2020.08.040
27. Online document Turkish Medicines and Medical Devices Agency. Instruction Manual. Turkish Medicines and Medical Devices Agency; 2020. https://titck.gov.tr/storage/Archive/2020/kubKtAttachments/Favimolkt_0f4b85df-7eef-4dc4-a25f-fe987d92e778.pdf. Accessed December 10, 2021.
28. Ji G, Wei W, Yue K, et al. Effects of the COVID-19 pandemic on obsessive-compulsive symptoms among university students: Prospective cohort survey study. J Med Internet Res. 2020;22(9):e21915. doi:10.2196/21915
29. Ojalehto HJ, Abramowitz JS, Hellberg SN, Butcher MW, Buchholz JL. Predicting COVID-19-related anxiety: The role of obsessive-compulsive symptom dimensions, anxiety sensitivity, and body vigilance. J Anxiety Disord. 2021;83:102460. doi:10.1016/j.janxdis.2021.102460
30. Shatri H, Prabu OG, Tetrasiwi EN, Faisal E, Putranto R, Ismail RI. The role of online psychotherapy in COVID-19: An evidence based clinical review. Acta Med Indones. 2021;53(3):352-359.